Omics Global Solutions


Omics Global Solutions (OGS) is a biotechnology company based in Puerto Rico, focused on developing and commercializing products related to OMICS sciences, including proteomics. The company aims to impact patients and medical professionals positively through innovative projects, such as the development of diagnostic tests like INNOVATIO ND2™ for diabetic nephropathy. With a mission to develop clinical prognostic products based on scientific models and a vision to be a leading biotech company in LATAM and the US by 2030, Omics is committed to high-quality standards and bringing science to the community.

Industries

biotechnology
health-care
life-science
medical
pharmaceutical

Nr. of Employees

small (1-50)

Omics Global Solutions


Products

ELISA assay for diabetic kidney disease diagnosis and risk stratification

An ELISA-format in vitro diagnostic assay that provides both diagnostic and prognostic measurements to identify risk of developing diabetic nephropathy in patients with type 2 diabetes.


Services

Assay development and technical transfer

Development of biomarker-based assays and execution of technical transfer strategies to enable commercial and clinical laboratory deployment.

Commercialization and distribution partnerships

Establishing regional distributor and clinical laboratory partnerships to introduce diagnostic assays into Latin American and U.S. markets.

Bioinformatics and data analysis support

Data analysis and bioinformatics applied to proteomics datasets to support precision-medicine research and interpretation.

Expertise Areas

  • Biomarker discovery and validation
  • Proteomics and clinical proteomics
  • In vitro diagnostic assay development (ELISA)
  • Antibody generation for diagnostics
  • Show More (4)

Key Technologies

  • Enzyme-linked immunosorbent assay (ELISA)
  • Proteomics
  • Antibody-based assays
  • Biomarker assays
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.